John A. Stalfort III, Director at Taysha Gene Therapies, Inc. (TSHA), bought 827,778 shares at $0.90 ($700K) on 2023-08-16, disclosed to the SEC on 2023-08-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 50,000 | $0 | 0.0% |
| 2 | $0.90 | 388,889 | $350K | 50.0% |
| 3 | $0.90 | 388,889 | $350K | 50.0% |
| Total | $0.85 avg | 827,778 | $700K | 100% |
| Filing → |